Volume 106, Issue 1 pp. 494-503
ORIGINAL ARTICLE - CLINICAL SCIENCE

Clinical Outcomes of Mitral Regurgitation Severity and Transcatheter Edge-to-Edge Repair in Atrial Functional Mitral Regurgitation

Jwan A. Naser

Corresponding Author

Jwan A. Naser

The Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA

Correspondence: Jwan A. Naser ([email protected])

Sorin V. Pislaru ([email protected])

Search for more papers by this author
Faysal Massad

Faysal Massad

The Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA

Search for more papers by this author
Christopher G. Scott

Christopher G. Scott

The Department of Quantitative Health Sciences and Biostatistics, Mayo Clinic, Rochester, Minnesota, USA

Search for more papers by this author
Barry A. Borlaug

Barry A. Borlaug

The Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA

Search for more papers by this author
Hector I. Michelena

Hector I. Michelena

The Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA

Search for more papers by this author
Trevor J. Simard

Trevor J. Simard

The Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA

Search for more papers by this author
Konstantinos C. Siontis

Konstantinos C. Siontis

The Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA

Search for more papers by this author
Austin M. Kennedy

Austin M. Kennedy

The Department of Quantitative Health Sciences and Biostatistics, Mayo Clinic, Rochester, Minnesota, USA

Search for more papers by this author
Jeremy J. Thaden

Jeremy J. Thaden

The Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA

Search for more papers by this author
Patricia A. Pellikka

Patricia A. Pellikka

The Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA

Search for more papers by this author
Vuyisile T. Nkomo

Vuyisile T. Nkomo

The Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA

Search for more papers by this author
Mackram F. Eleid

Mackram F. Eleid

The Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA

Search for more papers by this author
Sorin V. Pislaru

Corresponding Author

Sorin V. Pislaru

The Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA

Correspondence: Jwan A. Naser ([email protected])

Sorin V. Pislaru ([email protected])

Search for more papers by this author
First published: 04 May 2025

ABSTRACT

Background

Incident atrial functional mitral regurgitation (AFMR) is associated with mortality. Transcatheter edge-to-edge repair (TEER) has shown effectiveness in improving MR and symptoms in AFMR, but previous studies lacked comparison to conservative management. We aimed to study the association of AFMR severity and mitral TEER with symptoms, heart failure hospitalizations (HFH) and all-cause mortality in moderate/severe AFMR.

Methods

Consecutive adults with moderate/severe AFMR managed conservatively or with TEER 2010−2023 were identified retrospectively. To ensure similar technique in evaluation in the two groups, variables were obtained from the closest transthoracic echocardiogram before TEER in the TEER group. In addition to multivariable analysis, the association of TEER (vs. conservative management) with HFH and mortality was assessed using propensity-score matched analyses; the propensity score was based on age, sex, EuroSCORE II, effective regurgitant orifice area, integrative MR severity, and NYHA class III/IV (vs. I/II).

Results

Among 230 patients with moderate/severe AFMR [mean age 77; 56% females], 46 were managed with TEER. Severe (vs. moderate) AFMR was independently associated with baseline NYHA class III/IV (multivariable OR 2.18 [95% CI 1.13−4.26]) and HFH [multivariable HR 2.75 (95% CI 1.25−6.03)] but not mortality (p = 0.26). TEER improved MR to ≤ moderate in 93% but was not associated with lower HFH or death rates versus conservative management on multivariable or matched analysis. However, 1-year NYHA improved more with TEER versus conservative management in patients with baseline NYHA class III/IV (62% vs. 27%, p = 0.03). Rhythm control was associated with improved survival (HR 0.38 [0.15−0.98]).

Conclusions

AFMR severity was associated with symptoms and HFH but not mortality. MR severity and NYHA class improved with TEER, but the association of TEER with HF hospitalizations or death remains unproven. Randomized studies are needed to evaluate the potential role of TEER and rhythm control on outcomes in AFMR.

Conflicts of Interest

The authors declare no conflicts of interest.

Data Availability Statement

The data that support the findings of this study are available from the corresponding author upon reasonable request.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.